Skip to main content

Table 2 Summary statistics of MeDIP-seq data

From: Genome-wide analysis of cell-Free DNA methylation profiling with MeDIP-seq identified potential biomarkers for colorectal cancer

Sample

Number of total reads

Number of mapped reads

Total mapped read rate

Number of unique reads

Unique reads rate

J730

42,362,427

32,119,271

75.8%

26,454,305

82.4%

J056

29,652,736

21,442,064

72.3%

17,378,878

81.1%

J228

18,250,231

11,425,158

62.6%

9,003,634

78.8%

J474

19,015,432

10,281,561

54.1%

8,097,962

78.8%

C1

46,505,740

16,686,432

35.9%

2,089,072

12.5%

C2

18,918,360

11,095,194

58.7%

5,085,484

45.8%

C3

91,305,808

58,482,718

64.1%

8,453,424

14.5%

  1. Note: J730, J056, J228, and J474 represent patients with colorectal cancer; C1, C2, and C3 represent healthy controls